Mesoblast Ltd. revenue breakdown overview

Mesoblast Ltd. revenue for the last year amounted to 7.50 M USD, the most of which — 7.43 M USD — came from its highest performing source at the moment, Adult Stem Cell Technology, the year earlier bringing 9.72 M USD. The greatest contribution to the revenue figure was made by Australia, United States and Singapore — last year it brought Mesoblast Ltd. 7.43 M USD, and the year before that — 9.72 M USD.